[Boulder, Colorado] – [October 18, 2024] – Nephrolytics, Inc., a pioneer in AI-powered nephrology solutions, is excited to announce the formation of its Clinical Advisory Board and Strategic Advisory Board, comprised of leading healthcare experts, healthcare entrepreneurs and industry strategists. These advisory boards will play a pivotal role in shaping the future of nephrology care, leveraging their combined expertise to drive innovation, clinical excellence, and strategic growth.
Introducing the Clinical Advisory Board
The newly established Clinical Advisory Board brings together a diverse group of renowned nephrologists and healthcare leaders who share Nephrolytics’ vision of revolutionizing kidney care. This board will provide critical insights into the needs of nephrology practices and guide the development of Nephrolytics’ AI-driven solutions.
Members of the Clinical Advisory Board include:
- Alice Wei, MD: Physician Executive, former Strive Health CMO Office.
- Chris Larsen, MD: CEO, Arkana Labs
- Jesse Flaxenburg, MD: President, Pikes Peak Nephrology Associates.
- Irfan Agha, MD, MRCP: President, Dallas Renal Group (DRG)
- Tudor Oceneanu, MD, FASN: Nephrologist, Nephrophiles, LLC.
- Shafiq Cheema, MD: Chief of Nephrology, Allama Iqbal Medical University.
- Samir Damani, MD, PharmD, FACC: Founder of MD Revolution, Cardiologist.
“We are building something transformative at Nephrolytics, and having the support and insight of our Clinical Advisory Board will be pivotal in achieving our goals. Together, we are set to redefine nephrology care,” said Naeem Rahim M.D, FASN, Co-founder and Chief Medical Officer at Nephrolytics.
Introducing the Strategic Advisory Board
Nephrolytics has also assembled a Strategic Advisory Board featuring industry veterans who will help steer the company’s growth, partnerships, and market positioning. This board’s strategic guidance will be instrumental in navigating the complexities of the healthcare industry and scaling Nephrolytics’ impact.
Members of the Strategic Advisory Board include:
- David Norris: CEO, Affineon Health & Serial Entrepreneur.
- Adil Haider, MD, MPH: Dean, Aga Khan University Medical College, Serial Entrepreneur.
- Bhargavi Gorukanti: President and Co-founder, Summit Medical Consultants.
- Abu M Arif: President, Ameriprise Bank FSB & Ameriprise Certificate Co.
“Our Strategic Advisory Board members bring a wealth of experience in business, healthcare leadership, and innovation,” added Tina Gill, Co-founder and CEO at Nephrolytics. “Their insights will shape our strategic initiatives, allowing us to forge partnerships and expand our reach within the nephrology community.”
With the formation of these advisory boards, Nephrolytics is taking a significant step toward achieving its mission of providing smarter, AI-powered care solutions to nephrologists and healthcare providers. The company looks forward to the collaboration and insights these advisors will bring in improving patient outcomes and transforming nephrology care.
About Nephrolytics:
Nephrolytics is an AI-powered cloud platform focused on transforming the future of nephrology care. By leveraging advanced analytics and machine learning, Nephrolytics provides real-time insights to clinicians, empowering them to make data-driven decisions that enhance patient outcomes. The platform aims to bridge the gap between technology and healthcare, optimizing treatment plans and improving the quality of care for patients with kidney disease.
For media inquiries, please contact: hasan@nephrolytics.ai
Hasan Ayub
SVP of Business Development
hasan@nephrolytics.ai
+ 1 208-991-9170
www.nephrolytics.ai